407634-06-4

Basic information

• Product Name: 1-(3-METHOXYPROPYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID
• Synonyms: 5-keto-1-(3-methoxypropyl)pyrrolidine-3-carboxylic acid;BAS 03320469;SBB010999;TIMTEC-BB SBB010999;1-(3-METHOXYPROPYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID;1-(3-METHOXY-PROPYL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID;AKOS BC-2624
• CAS NO: 407634-06-4
• Molecular Formula: C9H15NO4
• Molecular Weight: 201.22
• Mol File: 407634-06-4.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(3-METHOXYPROPYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3-METHOXYPROPYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID(407634-06-4)
• EPA Substance Registry System: 1-(3-METHOXYPROPYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID(407634-06-4)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 407634-06-4(Hazardous Substances Data)

Usage

General Description

1-(3-Methoxypropyl)-5-oxo-3-pyrrolidinecarboxylic acid is a chemical compound with the molecular formula C10H17NO4. It belongs to the class of pyrrolidinecarboxylic acids and contains a pyrrolidine ring, a carboxylic acid group, and a ketone group. 1-(3-METHOXYPROPYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID is an intermediate in the synthesis of pharmaceuticals and organic compounds. It is also used as a building block in organic chemistry and drug development. Its properties and potential applications make it an important compound in various industries, including the pharmaceutical and chemical sectors.

Relevant articles and documents

CYCLIC AMINE BASE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT

Disclosed are novel compounds of the formula (I)or a pharmaceutically acceptable salt or solvate thereof, wherein R1 is formula (I) X is -0-, -C(R14)2- or -N(R)-; Z is -C(R14)2- or -N(R)-; t is 0, 1, 2 or 3; each R and R2 is independently H, alkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, alkenyl or alkynyl; each R14 is H, alkyl, alkenyl, alkynyl, halo, -CN, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, -OR35, -N(R24)(R25)or -SR35; R41 is alkyl, cycloalkyl, -S02(alkyl), -C(O)-alkyl, -C(O)-cycloalkyl or -alkyl-NH-C(O)CH3; and the remaining variables are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I and methods of treating cognitive or neurodegenerative diseases with compounds of formula (I). Also disclosed are pharmaceutical compositions and methods of treatment comprising compounds of formula I in combination with other agents useful in treating cognitive or neurodegenerative diseases.